Commercial Post-marketing oncology studies: Enabling faster recruitment and lower costs pharminent June 22, 2026
Commercial The first 14 days: How specialty programs set patients up for success pharminent June 22, 2026
Commercial Denali sells FDA voucher for $195M to support neurodegenerative pipeline pharminent June 19, 2026
Commercial ADA ’26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option pharminent June 8, 2026
Commercial Lilly and Novo face off at ADA 2026 as others seek to compete in obesity pharminent June 5, 2026
Commercial A year after Vertex’s big launch, pain drug research faces a pivotal moment pharminent May 12, 2026
Commercial Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls pharminent May 11, 2026
Commercial Novo’s CEO champions “record-breaking start” for Wegovy pill in US market pharminent May 8, 2026
Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
Commercial Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat pharminent May 5, 2026
Commercial Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch pharminent April 30, 2026
Commercial Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth pharminent April 30, 2026
Commercial Pfizer protects $6.4bn heart disease blockbuster from generics, for now pharminent April 29, 2026
Commercial Pfizer settles with generic drugmakers to protect blockbuster drug until 2031 pharminent April 29, 2026
Commercial Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’ pharminent April 29, 2026
Commercial Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies pharminent April 29, 2026
Commercial Pfizer deals extend patent life for a top-selling rare disease drug pharminent April 28, 2026
Commercial Daiichi Sankyo shares slip after delaying annual earnings report pharminent April 24, 2026
Commercial Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels pharminent April 24, 2026
Commercial Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs pharminent April 23, 2026
Commercial Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change pharminent April 23, 2026
Commercial The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground pharminent April 21, 2026
Commercial The Omnichannel Gap: Building the CRM of the Future for Patient Services pharminent April 20, 2026
Commercial Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool pharminent April 17, 2026
Commercial Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch pharminent April 17, 2026
Commercial Revolution doubles stock offering target to $2B following pancreatic cancer win pharminent April 16, 2026
